Back to
Quadrature Capital Ltd
AMLX
5 quarters
Position history for
Quadrature Capital Ltd's holdings in Amylyx Pharmaceuticals, Inc.
No. Quadrature Capital exited its AMLX (Amylyx Pharmaceuticals) position in Q1 2026. Its Q4 2025 13F listed 15,465 shares worth $186,817. Quadrature Capital first reported AMLX in Q1 2025 and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$44,986
Total Shares Change
-12,744
Quarter-by-Quarter History